If you’ve looked into tirzepatide and felt a little sticker shock, you’re not alone. Mounjaro and Zepbound, the two brand-name versions, list at over $1,000 per month without insurance. For most people pursuing weight loss, that price point isn’t sustainable. But tirzepatide is also one of the most effective medications in this category, producing average weight loss of over 20 percent of body weight in clinical trials at the highest doses. The question isn’t just whether it works. It’s whether you can access it without spending yourself out of treatment.<\/p>\n
Here’s every legitimate option for getting tirzepatide at a lower cost.<\/p>\n
Eli Lilly holds the patents on both Mounjaro and Zepbound, meaning no generic tirzepatide is available yet. The two brand versions contain the same active ingredient but are approved for different indications: Mounjaro for type 2 diabetes, Zepbound for chronic weight management. Both carry similar list prices, and insurance coverage, particularly for weight loss, remains inconsistent across plans.<\/p>\n
Understanding this patent and coverage structure is useful because it points you toward the strategies that actually work. Negotiating with your insurer is rarely the fastest path. Finding an alternative access point usually is.<\/p>\n
Compounded tirzepatide is the most meaningful cost reduction currently available. FDA-registered compounding pharmacies can legally prepare tirzepatide using the same active ingredient found in Mounjaro and Zepbound, typically at a significantly lower price point. Depending on the dose and the provider, compounded tirzepatide often runs between $250 and $500 per month, compared to $1,000-plus for the brand versions at retail.<\/p>\n
This is a legal pathway. Compounding pharmacies operate under federal and state oversight, and they can produce compounded versions of medications when a shortage exists or when the formulation differs from what’s commercially available. Many compounded tirzepatide preparations include additional ingredients such as B12, which aren’t found in the brand pens.<\/p>\n
Telehealth providers like TrimRx offer compounded tirzepatide through a straightforward process: complete an online consultation, receive a prescription if you qualify, and have the medication shipped to your home. Take the intake quiz<\/a> to find out if you’re a candidate.<\/p>\n Eli Lilly offers savings cards for both Mounjaro and Zepbound, but like most manufacturer programs, the eligibility rules are restrictive.<\/p>\n For Mounjaro, the savings card is designed for commercially insured patients with a diabetes diagnosis. Eligible patients may pay as little as $25 per month, but the program excludes Medicare, Medicaid, and uninsured patients paying out of pocket.<\/p>\n Zepbound has its own savings program as well. Lilly has also experimented with direct-to-patient pricing through its LillyDirect platform, which has offered Zepbound at reduced cash prices in certain situations. These programs shift frequently, so it’s worth checking the Lilly website directly for current availability.<\/p>\n For a detailed breakdown of what Mounjaro costs through GoodRx versus other options, Mounjaro Cost on GoodRx<\/a> walks through the numbers.<\/p>\n GoodRx and similar discount programs can reduce the out-of-pocket cost of brand-name tirzepatide at the pharmacy counter, but the savings have limits. Mounjaro and Zepbound through GoodRx typically still run between $900 and $1,100 per month depending on the pharmacy and dose. That’s a meaningful discount from the full list price, but it’s still a significant monthly expense for most people.<\/p>\n Where discount cards make more practical sense is when you have partial insurance coverage and need to cover a gap, or when you’re already committed to a brand-name version and want to compare prices across pharmacies before filling. Running the same prescription through two or three discount platforms before you fill it takes five minutes and can sometimes save $75 to $150 per fill.<\/p>\n For a look at how GoodRx pricing breaks down specifically for tirzepatide, Tirzepatide Cost on GoodRx<\/a> covers the details.<\/p>\n Some insurance plans do cover tirzepatide, particularly Mounjaro when prescribed for type 2 diabetes. Zepbound coverage for weight loss is more variable and often requires prior authorization with specific documentation.<\/p>\n If you have employer-sponsored insurance, it’s worth pulling up your formulary and checking whether tirzepatide appears, and at what tier. Plans that cover it for weight loss typically require a BMI of 30 or higher, or 27 or higher with a qualifying comorbidity such as hypertension, sleep apnea, or high cholesterol.<\/p>\n If your plan denies coverage, an appeal is possible. How to Appeal an Insurance Denial for Wegovy or Ozempic<\/a> outlines the process, and while it’s written with semaglutide in mind, the appeal framework applies to tirzepatide coverage denials as well.<\/p>\n Pre-tax dollars from a Health Savings Account or Flexible Spending Account can go toward tirzepatide when it’s prescribed for a qualifying medical condition. This doesn’t lower the sticker price, but it reduces the effective cost by 20 to 35 percent depending on your tax bracket, which is real money over the course of a year.<\/p>\n Can You Use an HSA or FSA for Ozempic or Compounded Semaglutide<\/a> explains how HSA and FSA eligibility works for GLP-1 medications, and the same principles apply to tirzepatide.<\/p>\n Where you get your prescription matters. In-person weight loss clinics frequently charge separate fees for consultations, follow-up visits, and monitoring, layering costs on top of what you’re already paying for the medication itself. Telehealth platforms tend to consolidate these into a single monthly cost that includes both the provider relationship and the medication.<\/p>\n Let’s say a patient is choosing between an in-person clinic charging $150 per visit plus brand Mounjaro at $1,000 per month, versus a telehealth provider offering compounded tirzepatide at $350 per month all in. The difference over a year is substantial, and the clinical outcomes from compounded tirzepatide, when sourced from a reputable pharmacy, aren’t meaningfully different because the active ingredient is the same.<\/p>\nOption 2: Eli Lilly Savings Programs<\/h3>\n
Option 3: GoodRx and Pharmacy Discount Cards<\/h3>\n
Option 4: Insurance Coverage<\/h3>\n
Option 5: HSA and FSA Dollars<\/h3>\n
Option 6: Telehealth vs. In-Person Clinics<\/h3>\n